Completed NA INTERVENTIONAL 2-arm NCT05381012

Fibromyalgia Syndrome on Patients With Chronic Migraine

The Effect of Fibromyalgia Syndrome on Female Patients With Chronic Migraine

Sponsor: Istanbul University - Cerrahpasa

Conditions Central Sensitisation Chronic Migraine, Headache Chronic Pain Syndrome Fibromyalgia Syndrome Headache Disorders

Interventions Allodynia, quality of life, sleep, anxiety and depression, disability, and central sensitization Fibromyalgia syndrome

Updated 7 times since 2022 Last updated: Sep 26, 2023 Started: May 1, 2022 Primary completion: Nov 1, 2022 Completion: Nov 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05381012, this NA trial focuses on Central Sensitisation and Chronic Migraine, Headache and remains completed. Sponsored by Istanbul University - Cerrahpasa, it has been updated 7 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Jan 2025 — Sep 2025 [monthly]

Completed NA
Sep 2024 — Jan 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 2 earlier versions

Feb 2023 — Oct 2023 [monthly]

Recruiting NA
Jun 2022 — Feb 2023 [monthly]

Recruiting NA

First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istanbul University - Cerrahpasa

Data source: Istanbul University - Cerrahpasa

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Istanbul, Turkey (Türkiye)